Y Intercept Hong Kong Ltd Takes Position in KORU Medical Systems, Inc. (NASDAQ:KRMD)

Y Intercept Hong Kong Ltd bought a new stake in shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) during the 4th quarter, according to its most recent filing with the SEC. The fund bought 26,924 shares of the company’s stock, valued at approximately $104,000. Y Intercept Hong Kong Ltd owned approximately 0.06% of KORU Medical Systems as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in KRMD. White Pine Capital LLC lifted its stake in KORU Medical Systems by 25.6% during the fourth quarter. White Pine Capital LLC now owns 157,917 shares of the company’s stock worth $608,000 after purchasing an additional 32,176 shares during the period. Calamos Advisors LLC bought a new position in shares of KORU Medical Systems during the 4th quarter worth approximately $250,000. Empire Financial Management Company LLC bought a new position in shares of KORU Medical Systems during the 3rd quarter worth approximately $259,000. Geode Capital Management LLC boosted its stake in KORU Medical Systems by 6.5% in the 3rd quarter. Geode Capital Management LLC now owns 462,128 shares of the company’s stock valued at $1,262,000 after buying an additional 28,323 shares in the last quarter. Finally, XTX Topco Ltd bought a new stake in KORU Medical Systems in the third quarter valued at $34,000. Institutional investors own 58.60% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on KRMD. Canaccord Genuity Group lifted their price objective on KORU Medical Systems from $3.00 to $4.00 and gave the company a “buy” rating in a report on Thursday, November 14th. Piper Sandler reissued a “neutral” rating and set a $4.50 price target on shares of KORU Medical Systems in a report on Friday, February 14th. Craig Hallum upped their price objective on shares of KORU Medical Systems from $5.00 to $6.00 and gave the stock a “buy” rating in a research note on Friday, January 17th. Finally, Lake Street Capital raised their price objective on shares of KORU Medical Systems from $4.00 to $5.00 and gave the stock a “buy” rating in a report on Tuesday, January 14th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $4.70.

KORU Medical Systems Stock Performance

KORU Medical Systems stock opened at $3.22 on Thursday. The stock has a 50-day simple moving average of $4.06 and a 200 day simple moving average of $3.36. The stock has a market capitalization of $147.60 million, a price-to-earnings ratio of -12.88 and a beta of 0.74. The company has a quick ratio of 2.37, a current ratio of 2.99 and a debt-to-equity ratio of 0.01. KORU Medical Systems, Inc. has a 12-month low of $2.04 and a 12-month high of $5.05.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.